CRISPR Therapeutics Announces Trials in Progress Poster Presentation at the 2021 American Society of Clinical Oncology Annual Meeting

NEXT STORY
FormFactor, Inc. Reports 2021 First Quarter Results
PREV STORY
US FDA Advisory Committee votes in favour of maintaining accelerated approval of Roche’s Tecentriq for previously untreated metastatic bladder cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

MIMEDX Receives Regulatory Approval to Commercialize EPIFIX® in Japan

author_avatar
NASDAQ Market News

Amarin and Mochida Announce Collaboration on Future Development of EPA-based Drug Products and Indications

BEDMINSTER, N.J. and DUBLIN, Ireland, June 12, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc ...

author_avatar
NASDAQ Market News

Interpace Diagnostics Group Reports Fourth Quarter and Full Year 2017 Financial Results, Business Progress Against Plan and Recent Accomplishments

Revenue for the Quarter Grew 40% over the Comparable Prior Year Quarter and 21% for ...

author_avatar
NASDAQ Market News